Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Schizophrenia
NCT01111149Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Dec 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in nicotine dependence, sponsored by University of Minnesota. Started Dec 2009; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01111149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111149.